Dictionary
The Dictionary provides concise definitions of health economics terms, arranged alphabetically for quick reference. Use it to understand unfamiliar terminology or confirm the meaning of a specific term.
E
- Evidence Generation Plan
- A prospectively developed strategy outlining what further clinical or real-world evidence will be collected after a technology's initial approval or reimbursement.
H
- Health Economics Plan
- A manufacturer's strategic document outlining planned economic modelling, real-world evidence studies, and health technology assessment submissions for a new technology.
M
- Modern Benefit Assessment
- A benefit assessment using current methodological standards, including patient-reported outcomes and real-world evidence, alongside traditional trial data.
- Modern Innovation Assessment
- An innovation assessment incorporating current methodological standards, including real-world evidence and post-market surveillance data, into evaluating a technology.
R
- Real-World Evidence
- Clinical evidence about a medical product's use, benefits, or risks derived from analysing real-world data, unlike evidence from a controlled trial.
- Real-World Evidence (RWE)
- An abbreviated term for real-world evidence, clinical conclusions drawn from analysing sources such as health records, claims, and patient registries.
- Real-World Evidence HTA
- The use of data from routine clinical practice, such as electronic health records, within an assessment to complement trial evidence.
V
- Value Demonstration
- The process of generating and presenting evidence establishing a technology's clinical and economic value, spanning trial results, real-world evidence, and modelling.